In cases where thrombocytopenia is refractory or severe, alternative strategies—such as the use of thrombopoietin receptor agonists—may be warranted, with close monitoring by nursing staff to assess both efficacy and potential side effects. Here, MPL is linked to Thrombocytopenia.